cervicogenic dizziness
Conditions
Interventions
Observation group:"Seven Needles for the Neck" acupuncture point selection: bilateral Fengchi (), Tianzhu (), Wangu (), Fengfu (), and corresponding acupoints for moxibustion and acupuncture.
Control Group:The patient was treated with Western medicine. Betahistine Dihydrochloride Tablets (produced by Lepu Hengjiuyuan Pharmaceutical Co., Ltd., National Drug Approval No. H41022374, 4 mg per
Sponsors
Hangzhou Linping District Traditional Chinese and Western Medicine Integrated Hospital
Eligibility
Sex/Gender
All
Age
16 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1)Meets the diagnostic criteria for CV diseases in both traditional Chinese and Western medicine; 2) Age between 16 and 65 years; 3) Able to cooperate with the research protocol and adhere to the treatment; 4) No relevant treatment received within the past month; 5) Voluntarily participates in this study, with the patient (and guardian) signing the informed consent form.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1)Other types of vertigo caused by cerebral arteriosclerosis, vascular stenosis, etc.; 2) Individuals with severe cardiovascular, cerebrovascular, respiratory system diseases, or mental disorders; 3) Pregnant or breastfeeding women; 4) Those who fear acupuncture or are allergic to the drugs used in this study; 5) Individuals receiving other medications or physical therapy treatments simultaneously.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ESC V Score;Hemodynamic indices; | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine Syndrome Scoring; | — |
Countries
China
Contacts
Public ContactJing Jie
Hangzhou Linping District Traditional Chinese and Western Medicine Integrated Hospital
Outcome results
None listed